Atypical Subacute Recurrence of Catastrophic Antiphospholipid Syndrome in a Japanese Female Patient

被引:3
作者
Horikoshi, Masanobu
Inokuma, Shigeko
Matsubara, Erika
Honda, Yasunori
Okada, Rika
Kobuna, Mika
Miura, Yoko
Kobayashi, Shoko
Kawai, Shigeo
Kumasaka, Toshio
机构
[1] Department of Allergy and Rheumatic Diseases, Japanese Red Cross Medical Center
[2] Department of Pathology, Japanese Red Cross Medical Center
关键词
catastrophic antiphospholipid syndrome; microangiopathic hemolytic anemia; relapse; rituximab; CLASSIFICATION; CRITERIA;
D O I
10.2169/internalmedicine.54.5150
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Catastrophic antiphospholipid syndrome (CAPS) survivors rarely relapse. We herein report a case of a second CAPS episode with an unusual subacute course and no microangiopathic hemolytic anemia (MAHA), a common CAPS symptom. During the first episode, the 69-year-old woman responded well to high-dose glucocorticoids and plasma exchange. On relapse, these treatments plus rituximab were ineffective and she died of multi-organ failure and bacterial cholangitis. The absence of MAHA and a subacute course do not exclude a CAPS recurrence.
引用
收藏
页码:2923 / 2927
页数:5
相关论文
共 15 条
[1]   Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[2]   Relapsing catastrophic antiphospholipid syndrome: Report of three cases [J].
Asherson, Ronald A. ;
Espinosa, Gerard ;
Menahem, Solomon ;
Yinh, Janet ;
Bucciarelli, Silvia ;
Bosch, Xavier ;
Cervera, Ricard .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 37 (06) :366-372
[3]   The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome [J].
Bucciarelli, S. ;
Espinosa, G. ;
Cervera, R. .
LUPUS, 2009, 18 (10) :905-912
[4]   Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura? [J].
Cerveny, KC ;
Sawitzke, AD .
LUPUS, 1999, 8 (06) :477-481
[5]   Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome [J].
Cervera, R ;
Font, J ;
Gómez-Puerta, JA ;
Espinosa, G ;
Cucho, M ;
Bucciarelli, S ;
Ramos-Casals, M ;
Ingelmo, M ;
Piette, JC ;
Shoenfeld, Y ;
Asherson, RA .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1205-1209
[6]   CAPS Registry [J].
Cervera, R. .
LUPUS, 2012, 21 (07) :755-757
[7]   Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry' [J].
Cervera, R. .
LUPUS, 2010, 19 (04) :412-418
[8]   Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome [J].
Cervera R. .
Current Rheumatology Reports, 2010, 12 (1) :70-76
[9]   Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the "CAPS Registry" [J].
Cervera, Ricard ;
Bucciarelli, Silvia ;
Plasin, Miguel A. ;
Gomez-Puerta, Jose A. ;
Plaza, Joan ;
Pons-Estel, Guillermo ;
Shoenfeld, Yehuda ;
Ingelmo, Miguel ;
Espinos, Gerard .
JOURNAL OF AUTOIMMUNITY, 2009, 32 (3-4) :240-245
[10]   Long term outcome of catastrophic antiphospholipid syndrome survivors [J].
Erkan, D ;
Asherson, RA ;
Espinosa, G ;
Cervera, R ;
Font, J ;
Piette, JC ;
Lockshin, MD .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (06) :530-533